Archive (english)

This is a translation of the table of contents. One article of each issue is translated and freely available.

table of contents

SPOT ON

SPRINT study on more intensive blood pressure treatment … significant questions still unsolved, first guidelines modified

ORBITA trial – last nail in the coffin for PCI in stable angina?

NEW ON THE MARKET

Cladribine (MAVENCLAD) for multiple sclerosis

BEWARE MISINFORMATION

VIRUPROTECT and ALGOVIR against colds?

IN BRIEF

No pain medication against uncomplicated cystitis

Once again: teriparatide (FORSTEO) against osteoporosis

CURRENT ADR NETWORK REPORT

Ethinyl estradiol + dienogest (VALETTE, generics) frequently prescribed despite unclear risk of thromboembolism

SIDE EFFECTS

Anaphylaxis with iron isomaltoside (MONOFER)

Hypersexuality with donepezil (ARICEPT, generics)
free

Fatal arrhythmia and other adverse effects with fingolimod (GILENYA)

e a-t ON THE INTERNET

Particularly drugs with a small or no additional benefit are advertised

Libido pill flibanserin (USA: ADDYI) – a billion dollar flop

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles